Back
Speaker illustration

Doctor Peizhi Wang

Beijing (China)

Peizhi Wang completed his medical degree at the Southern Medical University, China. Subsequently, he pursues his direct entry PhD/MD at the Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. Since 2023, he has been an invited PhD/MD student at the Center for Molecular Cardiology, University of Zurich, Switzerland. He mainly researches on risk score, cardiovascular diabetology, novel biomarkers etc.

Presentations Articles

External validation of the CA-AKI score in patients with acute coronary syndrome: A real-world cohort analysis from Asia

Event: ESC Congress 2024

Topic: Renal Failure and Cardiovascular Disease

Session: Impact of chronic kidney disease on cardiovascular outcomes

Access
Like
Thumbnail

Proenkephalin improves risk prediction in acute coronary syndromes: derivation and external validation of the KID-ACS risk score

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiovascular diseases: predictors of onset and prognosis

Access
Like
Thumbnail

L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

The impact of the high-density lipoprotein cholesterol levels on long-term poor prognosis in patients with acute coronary syndrome: observations from a multicenter Asian cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers and risk stratification in Acute Coronary Syndromes

Access
Like
Thumbnail

Effect of the stress hyperglycemia ratio on long-term outcome in older patients with coronary heart disease: a multicenter cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Secondary Prevention

Session: Novel topics in acute cardiac care

Access
Like
Thumbnail

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort

Event: ESC Preventive Cardiology 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session: Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources